File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Allopurinol reduces cardiac keap1 and activates NrF2/p62 to attenuate diabetic cardiomyopathy

TitleAllopurinol reduces cardiac keap1 and activates NrF2/p62 to attenuate diabetic cardiomyopathy
Authors
KeywordsCardiomyopathy
Diabetes Mellitus
Autophagy
Antioxidant
Issue Date2018
PublisherAmerican Heart Association. The Journal's web site is located at http://circ.ahajournals.org
Citation
American Heart Association's 2017 Scientific Sessions and Resuscitation Science Symposium, Anaheim, CA, 11-15 November 2017. In Circulation, 2018, v. 136 n. Suppl 1, article no. A17146 How to Cite?
AbstractIntroduction: Allopurinol (ALP), a xanthine oxidase inhibitor, attenuates diabetes-induced oxidative stress and diabetic cardiomyopathy(DCM), but the mechanism is unclear. Activation of Nuclear factor erythroid 2-related factor-2 (Nrf2) following the disassociation with its repressor Keap1 under oxidative stress plays key roles in maintaining inner redox homeostasis and in attenuating DCM, which is associated with attenuation of autophagy and upregulation of SQSTM1/P62. However, the interactions among Keap1, Nrf2 and p62 in DCM and in ALP-mediated attenuation of DCM is unknown. We postulated that suppressing Keap1 and the subsequent activation of Nrf2 and mitigating autophagy over activation may represent major mechanisms whereby ALP attenuates DCM. Methods and Results: Streptozotocin-induced diabetic (D) rats were untreated or treated with allopurinol (100 mg/kg/day, n=6 per group) for 1 week starting at 4 weeks of diabetes induction, and terminated after measuring left ventricular (LV) function by echocardiography. D rats demonstrated asymptomatic cardiac dysfunction manifested as significant reductions in heart rate(HR), left ventricular eject fraction(LVEF), stroke work(SW) and cardiac output(CO), Left ventricular end-systolic volume (LVVs)) as compared to non-diabetic control (all p<0.05) and ALP improved or normalized HR, LVEF, SW, CO, LVVs in D rats(all p<0.05, vs. diabetic untreated). Biochemically, hearts of D rats displayed excessive oxidative stress manifested as increased levels of 15-F2t-Isoprostane, increased apoptotic cell death and cardiomyocyte autophagy (enhanced LC3 II/I ratio) that were concomitant with increased Nrf2 and Nrf2- antioxidant-response element (ARE) (HO-1 expression, superoxide dysmutase activity and catalase expression) but decreased P62 expression. ALP reverted all the above mentioned diabetes-induced biochemical changes except that it further activated Nrf2 with concomitant inhibition of the Nrf2 repressor Keap1. Conclusion: Suppressing Keap1 and the subsequent activation of Nrf2 and p62 to mitigate apoptosis and autophagy over activation may represent major mechanisms whereby ALP attenuates DCM and cardiac dysfunction.
Persistent Identifierhttp://hdl.handle.net/10722/258529
ISSN
2017 Impact Factor: 18.881
2015 SCImago Journal Rankings: 7.853

 

DC FieldValueLanguage
dc.contributor.authorLuo, J-
dc.contributor.authorYan, D-
dc.contributor.authorLi, S-
dc.contributor.authorHuang, H-
dc.contributor.authorLiu, S-
dc.contributor.authorIrwin, MG-
dc.contributor.authorXia, Z-
dc.date.accessioned2018-08-22T01:39:58Z-
dc.date.available2018-08-22T01:39:58Z-
dc.date.issued2018-
dc.identifier.citationAmerican Heart Association's 2017 Scientific Sessions and Resuscitation Science Symposium, Anaheim, CA, 11-15 November 2017. In Circulation, 2018, v. 136 n. Suppl 1, article no. A17146-
dc.identifier.issn0009-7322-
dc.identifier.urihttp://hdl.handle.net/10722/258529-
dc.description.abstractIntroduction: Allopurinol (ALP), a xanthine oxidase inhibitor, attenuates diabetes-induced oxidative stress and diabetic cardiomyopathy(DCM), but the mechanism is unclear. Activation of Nuclear factor erythroid 2-related factor-2 (Nrf2) following the disassociation with its repressor Keap1 under oxidative stress plays key roles in maintaining inner redox homeostasis and in attenuating DCM, which is associated with attenuation of autophagy and upregulation of SQSTM1/P62. However, the interactions among Keap1, Nrf2 and p62 in DCM and in ALP-mediated attenuation of DCM is unknown. We postulated that suppressing Keap1 and the subsequent activation of Nrf2 and mitigating autophagy over activation may represent major mechanisms whereby ALP attenuates DCM. Methods and Results: Streptozotocin-induced diabetic (D) rats were untreated or treated with allopurinol (100 mg/kg/day, n=6 per group) for 1 week starting at 4 weeks of diabetes induction, and terminated after measuring left ventricular (LV) function by echocardiography. D rats demonstrated asymptomatic cardiac dysfunction manifested as significant reductions in heart rate(HR), left ventricular eject fraction(LVEF), stroke work(SW) and cardiac output(CO), Left ventricular end-systolic volume (LVVs)) as compared to non-diabetic control (all p<0.05) and ALP improved or normalized HR, LVEF, SW, CO, LVVs in D rats(all p<0.05, vs. diabetic untreated). Biochemically, hearts of D rats displayed excessive oxidative stress manifested as increased levels of 15-F2t-Isoprostane, increased apoptotic cell death and cardiomyocyte autophagy (enhanced LC3 II/I ratio) that were concomitant with increased Nrf2 and Nrf2- antioxidant-response element (ARE) (HO-1 expression, superoxide dysmutase activity and catalase expression) but decreased P62 expression. ALP reverted all the above mentioned diabetes-induced biochemical changes except that it further activated Nrf2 with concomitant inhibition of the Nrf2 repressor Keap1. Conclusion: Suppressing Keap1 and the subsequent activation of Nrf2 and p62 to mitigate apoptosis and autophagy over activation may represent major mechanisms whereby ALP attenuates DCM and cardiac dysfunction.-
dc.languageeng-
dc.publisherAmerican Heart Association. The Journal's web site is located at http://circ.ahajournals.org-
dc.relation.ispartofCirculation-
dc.subjectCardiomyopathy-
dc.subjectDiabetes Mellitus-
dc.subjectAutophagy-
dc.subjectAntioxidant-
dc.titleAllopurinol reduces cardiac keap1 and activates NrF2/p62 to attenuate diabetic cardiomyopathy-
dc.typeConference_Paper-
dc.identifier.emailIrwin, MG: mgirwin@hku.hk-
dc.identifier.emailXia, Z: zyxia@hkucc.hku.hk-
dc.identifier.authorityIrwin, MG=rp00390-
dc.identifier.authorityXia, Z=rp00532-
dc.identifier.hkuros287315-
dc.identifier.volume136-
dc.identifier.issueSuppl 1-
dc.identifier.spagearticle no. A17146-
dc.identifier.epagearticle no. A17146-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats